Skip to main content
. 2018 Aug 27;10:1053–1071. doi: 10.2147/CLEP.S166309

Table S7.

Baseline characteristics of hip fracture patients (n=68,487) according to preoperative selective serotonin reuptake inhibitor (SSRI) use 2006–2016 after changing the exposure definition

Variables All patients
SSRIs
Non-users
Former users
Current users
n % n % n % n %
Total 68,487 100 52,841 77.2 1,116 1.6 14,530 21.2
Median age (years) 83 83 82 84
Age (years)
 65–74 13,271 19.4 10,620 20.1 230 20.6 2,421 16.6
 75–84 26,086 38.1 19,910 37.7 487 43.6 5,689 39.2
 ≥85 29,130 42.5 22,311 42.2 399 35.8 6,420 44.2
Gender
 Male 19,750 28.8 15,690 29.7 274 24.5 3,786 26.1
 Female 48,737 71.2 37,151 70.3 842 75.5 10,744 73.9
Marital status
 Married 20,300 29.6 16,247 30.7 320 28.7 3,733 25.7
 Unmarried 48,187 70.4 36,594 69.3 796 71.3 10,797 74.3
Housing
 Own accommodation 31,075 45.4 25,728 48.7 414 37.1 4,933 33.9
 Homeless 22 <0.1 17 <0.1 3 0.3 2 <0.1
 Residential institution 7,150 10.4 4,232 8.0 190 17.0 2,683 18.5
 Unknown 30,285 44.2 22,864 43.3 509 45.6 6,912 47.6
Fracture type
 Fracture of femoral neck 36,341 53.1 28.073 53.1 595 53.3 7.673 52.8
 Per- and subtrochanteric fracture 32,146 46.9 24,768 46.9 521 46.7 6,857 47.2
Operation type
 Alloplastic surgery 46,859 68.4 36,122 68.4 761 68.2 9,976 68.7
 Osteosynthesis 21,628 31.6 16,719 31.6 355 31.8 4,554 31.3
Operation delay (hours)
 <24 41,671 60.8 32,090 60.7 700 62.7 8,881 61.1
 24–48 12,517 18.3 9,715 18.4 196 17.6 2,606 17.9
 >48 14,299 20.9 11,036 20.9 220 19.7 3,043 21.0
Operation year
 2006–2010 32,131 46.9 24,061 45.5 539 48.3 7,531 51.8
 2011–2016 36,356 53.1 28,780 54.5 577 51.7 6,999 48.2
BMI (kg/m2)
 <18.5: underweight 5,988 8.8 4,623 8.7 104 9.3 1,261 8.7
 ≥18.5 <25: normal weight 31,582 46.1 24,630 46.6 492 44.1 6,460 44.5
 ≥25: overweight or obese 17,622 25.7 13,616 25.8 292 26.2 3,714 25.5
 Unknown 13,295 19.4 9,972 18.9 228 20.4 3,095 21.3
Charlson Comorbidity Index
 Low (0) 27,283 39.8 22,655 42.9 339 30.4 4,289 29.5
 Medium (1–2) 27,787 40.6 20,544 38.9 494 44.3 6,749 46.5
 High (3+) 13,417 19.6 9,642 18.2 283 25.3 3,492 24.0
Comorbidity
 Myocardial infarction 3,762 5.5 2,848 5.4 57 5.1 857 5.9
 Congestive heart failure 6,289 9.2 4,677 8.9 125 11.2 1,487 10.2
 Peripheral vascular disease 5,511 8.1 4,092 7.7 112 10.0 1,307 9.0
 Cerebrovascular disease 12,678 18.5 8,549 16.2 278 24.9 3,851 26.5
 Dementia 6,733 9.8 3,891 7.4 172 15.4 2,670 18.4
 Chronic pulmonary disease 8,663 12.7 6,229 11.8 187 16.8 2,247 15.5
 Connective tissue disease 3,243 4.7 2,495 4.7 60 5.4 688 4.7
 Ulcer disease 3,855 5.6 2,693 5.1 81 7.3 1,081 7.4
 Liver disease 870 1.3 647 1.2 24 2.2 199 1.4
 Diabetes type 1 and 2 6,689 9.8 5,041 9.5 131 11.7 1,517 10.4
 Hemiplegia 175 0.3 112 0.2 3 0.3 60 0.4
 Moderate to severe renal disease 2,688 3.9 1,995 3.8 54 4.8 639 4.4
 Cancer 10,957 16.0 8,440 16.0 175 15.7 2,342 16.1
Other medication
 NSAIDs 7,681 11.2 5,926 11.2 128 11.5 1,627 11.2
 Corticosteroids 4,158 6.1 3,100 5.9 86 7.7 972 6.7
 Anticoagulants 26,716 39.0 19,520 36.9 425 38.1 6,771 46.6
 Statins 13,052 19.1 9,698 18.4 182 16.3 3,172 21.8
 Other antidepressants 7,975 11.6 4,905 9.3 372 33.3 2,698 18.6
 Antipsychotics 4,992 7.3 2,897 5.5 165 14.8 1,930 13.3

Abbreviation: NSAIDs, non-steroidal anti-inflammatory drugs.